The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to ...

The industry-leading range of Sartorius Ambr multi-parallel bioreactors has been developed to take scientists through the early steps of their upstream process from cell selection, through to process ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

Goettingen | Guxhagen, Germany, September 12, 2012 / - Today on Wednesday, Sartorius, the Goettingen-based laboratory and pharmaceutical supplier, formally opened its new plant in Guxhagen in northern ...

CultiFlask 50 disposable bioreactors from Sartorius offer a fast and economical approach for performing many parallel cell cultivation experiments. Being superior to tissue culture flasks in maximum ...

Sartorius AG is expanding its role as a key supplier of bioprocessing equipment and consumables, with investors watching how demand for biologics and cell therapies supports long-term revenue growth.